GOLD-SPECIFIC T-CELLS IN RHEUMATOID-ARTHRITIS PATIENTS TREATED WITH GOLD

被引:95
作者
ROMAGNOLI, P
SPINAS, GA
SINIGAGLIA, F
机构
[1] F HOFFMANN LA ROCHE & CO LTD, PHARMA RES TECHNOL, CH-4002 BASEL, SWITZERLAND
[2] KANTONSSPITAL, DEPT INTERNAL MED & RES, CH-4002 BASEL, SWITZERLAND
关键词
ANTIGEN PRESENTATION; MHC CLASS-II MOLECULE; GOLD; HUMAN T-CELL CLONES; DELAYED TYPE HYPERSENSITIVITY;
D O I
10.1172/JCI115569
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Gold-specific T lymphocyte clones were isolated from a patient with rheumatoid arthritis who developed delayed type hypersensitivity reactions to gold. All of the isolated T cell clones required histocompatible antigen presenting cells as well as gold for induction of proliferation. Using a panel of HLA-homozygous Epstein Barr virus-transformed B (EBV-B) cells and anti-HLA antibodies, the clones were shown to recognize gold in the context of DR1 molecules. Gold recognition did not require active antigen processing since specific proliferation was not affected by glutaraldehyde fixation of the DR1 homozygous antigen presenting cells. Furthermore, we could show that gold salts inhibited peptide-induced responses of a peptide-specific T cell clone. In addition to providing evidence for gold-specific T cells in gold-treated RA patients exhibiting delayed type hypersensitivity responses, these data suggest that gold can alter MHC-peptide complexes. The latter observation may in part explain the mechanism/s responsible for both the therapeutic and the toxic effects of gold.
引用
收藏
页码:254 / 258
页数:5
相关论文
共 31 条
[1]  
[Anonymous], 1960, ANN RHEUM DIS, V19, P95
[2]   BINDING OF IMMUNOGENIC PEPTIDES TO IA HISTOCOMPATIBILITY MOLECULES [J].
BABBITT, BP ;
ALLEN, PM ;
MATSUEDA, G ;
HABER, E ;
UNANUE, ER .
NATURE, 1985, 317 (6035) :359-361
[3]   THE RELATION BETWEEN MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) RESTRICTION AND THE CAPACITY OF IA TO BIND IMMUNOGENIC PEPTIDES [J].
BUUS, S ;
SETTE, A ;
COLON, SM ;
MILES, C ;
GREY, HM .
SCIENCE, 1987, 235 (4794) :1353-1358
[4]   PRESENT STATUS OF GOLD THERAPY FOR RHEUMATOID ARTHRITIS [J].
FREYBERG, RH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1950, 143 (05) :418-421
[5]  
FROLAND SS, 1973, SCAND J IMMUNOL, V2, P67
[6]   VACCINE T-CELL EPITOPE SELECTION BY A PEPTIDE COMPETITION ASSAY [J].
KILGUS, J ;
ROMAGNOLI, P ;
GUTTINGER, M ;
STUBER, D ;
ADORINI, L ;
SINIGAGLIA, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (05) :1629-1633
[7]   REMISSION-INDUCING THERAPY IN RHEUMATOID-ARTHRITIS [J].
LIPSKY, PE .
AMERICAN JOURNAL OF MEDICINE, 1983, 75 (4B) :40-49
[8]   INHIBITION OF ANTIGEN-INDUCED AND MITOGEN-INDUCED HUMAN LYMPHOCYTE-PROLIFERATION BY GOLD COMPOUNDS [J].
LIPSKY, PE ;
ZIFF, M .
JOURNAL OF CLINICAL INVESTIGATION, 1977, 59 (03) :455-466
[9]   A ONE-RECEPTOR VIEW OF T-CELL BEHAVIOR [J].
MATZINGER, P .
NATURE, 1981, 292 (5823) :497-501
[10]   NON-SPECIFIC LYMPHOCYTE TRANSFORMATION IN-VITRO BY NICKEL ACETATE - A POSSIBLE SOURCE OF ERRORS IN LYMPHOCYTE TRANSFORMATION TEST (LTT) [J].
PAPPAS, A ;
ORFANOS, CE ;
BERTRAM, R .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1970, 55 (03) :198-&